Name:	O
___.	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Percocet	O
/	O
Atorvastatin	O
/	O
alprazolam	O
/	O
oxytocin	O
/	O
Demerol	O
/	O
Codeine	O
/	O
lorazepam	O
/	O
Cyclobenzaprine	O
/	O
narcotic	O
pain	O
medication	O
/	O
amiodarone	O
Attending:	O
___.	O
Chief	O
Complaint:	O
ICD	O
firing	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
AV	O
nodal	O
ablation	O
and	O
R	O
bundle	O
branch	O
ablation:	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
known	O
CAD	O
___	O
CABG	O
___	O
and	O
redo	O
sternomoty	O
with	O
tissue	O
MVR	O
2	O
months	O
ago	O
for	O
4+	O
MR,	O
systolic	O
heart	O
failure	O
(LVEF	O
35%,	O
has	O
BiV	O
pacer	O
for	O
LBBB)	O
sand	O
ICD	O
for	O
primary	O
prevention	O
presenting	O
to	O
the	O
ED	O
following	O
VT	O
storm	O
this	O
morning	O
with	O
ICD	O
firing	O
x2.	O
Patient	O
reports	O
that	O
she	O
has	O
never	O
recovered	O
back	O
to	O
her	O
baseline	O
since	O
the	O
surgery.	O
She	O
has	O
felt	O
dyspnea	O
and	O
chest	O
tightness	O
with	O
any	O
exertion,	O
even	O
walking	O
the	O
stairs	O
in	O
her	O
house.	O
This	O
has	O
not	O
necessarily	O
gotten	O
worse	O
since	O
her	O
cardiac	O
cath	O
immediately	O
prior	O
to	O
her	O
MVR.	O
Today,	O
she	O
did	O
her	O
usual	O
job	O
as	O
a	O
___	O
and	O
felt	O
fine.	O
She	O
then	O
went	O
to	O
the	O
market	O
and	O
felt	O
dizzy	O
and	O
went	O
home.	O
She	O
then	O
took	O
a	O
shower	O
and	O
as	O
she	O
was	O
walking	O
she	O
felt	O
two	O
shocks	O
in	O
succession.	O
She	O
was	O
not	O
dizzy	O
before	O
the	O
shock	O
and	O
she	O
did	O
not	O
lose	O
consiousness	O
at	O
any	O
point.	O
En	O
route	O
to	O
the	O
ED,	O
she	O
was	O
off	O
and	O
on	O
in	O
a	O
wide	O
complex	O
tachycardia	O
on	O
the	O
monitor	O
with	O
sustained	O
rates	O
in	O
the	O
170	O
range	O
and	O
was	O
loaded	O
by	O
EMS	O
with	O
150mg	O
amiodarone	O
IV	O
in	O
the	O
ED.	O
Patient	O
denies	O
orthopnea,	O
PND,	O
no	O
increasing	O
weight,	O
no	O
fevers/	O
chills,	O
she	O
has	O
been	O
taking	O
her	O
medicines	O
without	O
difficulty.	O
Past	O
Medical	O
History:	O
-	O
Systolic	O
congestive	O
heart	O
failure	O
___:	O
EF	O
35%	O
-	O
Mitral	O
regurgitation	O
___	O
-	O
Coronary	O
artery	O
disease,	O
NSTEMI	O
___	O
___	O
CABG	O
x	O
___,	O
___	O
multiple	O
PCIs,	O
mostly	O
to	O
LAD	O
*	O
___:	O
NSTEMI	O
___	O
coronary	O
atherectomies	O
to	O
LAD/D1	O
bifurcation	O
lesion	O
with	O
placment	O
of	O
2	O
stents	O
and	O
PTCA	O
to	O
jailed	O
D1	O
*	O
___:	O
Elective	O
cath	O
revealed	O
in-stent	O
restenosis	O
and	O
90%D1	O
restenosis;	O
PTCRA	O
was	O
performed	O
for	O
in-stent	O
restenosis	O
as	O
well	O
as	O
kissing	O
balloons	O
to	O
LAD/D1	O
with	O
residual	O
20%	O
D1	O
lesion	O
*	O
___:	O
UA	O
with	O
cath/no	O
intervention	O
but	O
LVEDP	O
38	O
*	O
___:	O
Chest	O
pain	O
with	O
diagnostic	O
cath	O
showing	O
widely	O
patent	O
LIMA-LAD	O
and	O
SVG-D1-OM1.	O
LMCA	O
with	O
50%	O
stenosis,	O
LAD	O
with	O
80%	O
proximal	O
and	O
mid,	O
LCx	O
with	O
70-80%	O
proximal,	O
and	O
RCA	O
with	O
80%	O
ostial	O
lesion.	O
LVEDP	O
severely	O
elevated	O
to	O
36	O
mmHg.	O
*	O
RHC	O
on	O
___	O
showed	O
mean	O
wedge	O
of	O
20	O
and	O
CO	O
of	O
2.871	O
L/min	O
-	O
PACING/ICD:	O
-	O
___	O
Hx	O
NSVT	O
on	O
telemetry	O
in	O
the	O
setting	O
of	O
MI,	O
sustained	O
T-wave	O
alternans	O
on	O
stress	O
testing	O
(worked	O
up	O
for	O
ICD	O
but	O
none	O
placed)	O
-	O
___	O
AICD	O
-	O
BiV	O
pacer	O
___	O
-	O
Chronic	O
atrial	O
fibrillation,	O
on	O
Coumadin	O
-	O
Peripheral	O
vascular	O
disease	O
-	O
Diabetes	O
mellitus	O
-	O
Hypothyroidism	O
-	O
Nephrolithiasis	O
___	O
right	O
nephrectomy,	O
creatinine	O
1.1-1.4	O
baseline)	O
-	O
Plantar	O
fasciitis	O
-	O
Reflux	O
esophagitis,	O
peptic	O
ulcer	O
disease,	O
GERD	O
-	O
GI	B-Upper_gastrointestinal_haemorrhage
Bleed	B-Upper_gastrointestinal_haemorrhage
___	O
-	O
Peripheral	O
neuropathy	O
Past	O
Surgical	O
History:	O
-	O
___	O
CABG	O
x	O
___	O
-	O
___	O
right	O
nephrectomy	O
-	O
___	O
AICD	O
-	O
BiV	O
pacer	O
___	O
-	O
___	O
right	O
inguinal	O
hernia	O
operations	O
x	O
___	O
-	O
___	O
laparoscopic	O
cholecystectomy	O
___	O
___)	O
-	O
___	O
hysterectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
had	O
CHF,	O
died	O
at	O
age	O
___.	O
Otherwise	O
no	O
signficant	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death.	O
Physical	O
Exam:	O
ADMISSION:	O
Vitals:	O
Wt	O
73.9	O
kg	O
97.8	O
69	O
127/72	O
99%	O
RA	O
Gen:	O
Pleasant,	O
calm	O
HEENT:	O
No	O
conjunctival	O
pallor.	O
No	O
icterus.	O
MMM.	O
OP	O
clear.	O
NECK:	O
Supple,	O
No	O
LAD.	O
JVP	O
15	O
cm	O
H20	O
with	O
large	O
V	O
waves.	O
Normal	O
carotid	O
upstroke	O
without	O
bruits.	O
No	O
thyromegaly.	O
CV:	O
PMI	O
in	O
___	O
intercostal	O
space,	O
mid	O
clavicular	O
line.	O
RRR.	O
normal	O
S1,S2.	O
___	O
systolic	O
blowing	O
murmur,	O
no	O
rubs,	O
clicks,	O
or	O
gallops	O
LUNGS:	O
CTAB.	O
No	O
wheezes,	O
rales,	O
or	O
rhonchi.	O
ABD:	O
NABS.	O
Soft,	O
NT,	O
ND.	O
No	O
HSM.	O
Abdominal	O
aorta	O
was	O
not	O
enlarged	O
by	O
palpation.	O
No	O
abdominal	O
bruits.	O
EXT:	O
WWP,	O
NO	O
CCE.	O
Full	O
distal	O
pulses	O
bilaterally.	O
No	O
femoral	O
bruits.	O
SKIN:	O
No	O
rashes/lesions,	O
ecchymoses.	O
NEURO:	O
A&Ox3.	O
CN	O
___	O
grossly	O
intact.	O
Preserved	O
sensation	O
throughout.	O
___	O
strength	O
throughout.	O
___	O
reflexes,	O
equal	O
___.	O
Normal	O
coordination.	O
Gait	O
assessment	O
deferred	O
PSYCH:	O
Mood	O
was	O
tearful	O
and	O
affect	O
was	O
appropriate	O
DISCHARGE:	O
73.2	O
kg	O
(73.9	O
kg)	O
98.4	O
HR	O
80	O
AF	O
RR	O
16	O
98%	O
RA	O
112/67	O
(90/49-122/72)	O
Yest:	O
-500.	O
Gen:	O
Pleasant,	O
calm	O
HEENT:	O
No	O
conjunctival	O
pallor.	O
No	O
icterus.	O
MMM.	O
OP	O
clear.	O
NECK:	O
Supple,	O
No	O
LAD.	O
JVP	O
15	O
cm	O
H20	O
with	O
large	O
V	O
waves.	O
CV:	O
RRR	O
no	O
m/r/g.	O
LUNGS:	O
CTAB.	O
No	O
wheezes,	O
rales,	O
or	O
rhonchi.	O
ABD:	O
NABS.	O
Soft,	O
NT,	O
ND.	O
No	O
HSM..	O
EXT:	O
WWP,	O
NO	O
CCE.	O
Full	O
distal	O
pulses	O
bilaterally.	O
Pertinent	O
Results:	O
ADMIT:	O
___	O
11:19AM	O
BLOOD	O
WBC-9.2	O
RBC-4.43#	O
Hgb-12.1	O
Hct-38.6#	O
MCV-87#	O
MCH-27.4#	O
MCHC-31.4	O
RDW-17.0*	O
Plt	O
___	O
___	O
11:19AM	O
BLOOD	O
___	O
PTT-40.6*	O
___	O
___	O
11:19AM	O
BLOOD	O
Glucose-221*	O
UreaN-26*	O
Creat-2.1*	O
Na-134	O
K-7.8*	O
Cl-103	O
HCO3-21*	O
AnGap-18	O
___	O
11:19AM	O
BLOOD	O
Calcium-9.1	O
Phos-4.4#	O
Mg-2.3	O
___	O
11:34AM	O
BLOOD	O
Lactate-3.0*	O
K-4.9	O
___	O
07:41PM	O
BLOOD	O
Lactate-3.5*	O
IMAGING:	O
TTE:	O
IMPRESSION:	O
Moderate	O
left	O
ventricular	O
cavity	O
dilation	O
with	O
severe	O
systolic	O
dysfunction.	O
Well-seated	O
and	O
normally	O
functioning	O
mitral	O
bioprosthesis.	O
Severe	O
tricuspid	O
regurgitation.	O
Pulmonary	O
artery	O
hypertension.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
left	O
ventricular	O
systolic	O
function	O
has	O
declined.	O
The	O
severity	O
of	O
tricuspid	O
regurgitation	O
has	O
increased.	O
Pulmonary	O
artery	O
pressures	O
are	O
higher.	O
A	O
mitral	O
valve	O
bioprosthesis	O
is	O
now	O
present.	O
CXR:	O
IMPRESSION:	O
Mild	O
pulmonary	O
vascular	O
congestion.	O
MICRO:	O
NEGATIVE:	O
___	O
CULTUREBlood	O
Culture,	O
Routine-FINALEMERGENCY	O
WARD	O
DISCHARGE:	O
___	O
07:00AM	O
BLOOD	O
WBC-6.8	O
RBC-3.91*	O
Hgb-10.6*	O
Hct-33.2*	O
MCV-85	O
MCH-27.1	O
MCHC-32.0	O
RDW-17.4*	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
___	O
PTT-37.6*	O
___	O
___	O
07:00AM	O
BLOOD	O
Glucose-70	O
UreaN-53*	O
Creat-2.4*	O
Na-139	O
K-3.5	O
Cl-100	O
HCO3-24	O
AnGap-19	O
___	O
07:00AM	O
BLOOD	O
Calcium-9.3	O
Phos-3.8#	O
Mg-2.4	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
___	O
F	O
with	O
systolic	O
heart	O
failure,	O
AFib,	O
and	O
MR	O
___	O
recent	O
MVR	O
who	O
was	O
admitted	O
with	O
suabcute	O
DOE	O
and	O
acutely	O
with	O
diziness	O
and	O
after	O
receiving	O
ICD	O
shocks	O
x2.	O
EKG	O
captured	O
a	O
regular,	O
wide	O
complex	O
tachycardia.	O
This	O
was	O
felt	O
to	O
be	O
VT.	O
The	O
trigger	O
was	O
likely	O
adrenergic	O
surges	O
from	O
de	O
compensating	O
LV	O
systolic	O
function	O
vs	O
a	O
bundle	O
branch	O
reentry.	O
She	O
was	O
treated	O
with	O
amiodarone.	O
Her	O
subacute	O
presentation	O
with	O
DOE	O
was	O
felt	O
to	O
be	O
from	O
worsening	O
LV	O
systolic	O
function	O
from	O
persistent	O
Afib	O
that	O
was	O
preventing	O
BiV	O
pacing.	O
She	O
underwent	O
AV	O
nodal	O
ablation	O
(as	O
well	O
as	O
R	O
bundle	O
ablation	O
to	O
prevent	O
RBB-reentrant	O
VT).	O
She	O
was	O
discharged	O
with	O
symptomatic	O
improvement.	O
#	O
VT:	O
Regular	O
wide	O
complex	O
tachyardia	O
of	O
two	O
morophologies,	O
one	O
of	O
which	O
was	O
LBBB	O
morphology.	O
Not	O
inducible	O
in	O
cath	O
lab.	O
She	O
got	O
about	O
3.5	O
g	O
of	O
amio	O
loaded	O
over	O
four	O
days	O
and	O
was	O
continued	O
on	O
amiodarone	O
200	O
mg	O
daily	O
to	O
continue	O
until	O
she	O
sees	O
her	O
EP	O
cardiologist	O
next.	O
She	O
had	O
no	O
further	O
ventricular	O
tachycardia	O
in	O
the	O
hospital.	O
Her	O
digoxin	O
dose	O
was	O
halved	O
while	O
on	O
amiodarone.	O
She	O
underwent	O
Right	O
bundle	O
branch	O
ablation	O
(+AVNodal	O
ablation)	O
in	O
case	O
the	O
VT	O
resulted	O
from	O
RB	O
reentry.	O
Precipitants	O
of	O
the	O
VT	O
were	O
likely	O
to	O
be	O
either	O
inferior	O
scar,	O
worsening	O
CHF,	O
or	O
possibly	O
bundle	O
branch	O
reentry.	O
Trops	O
.___-.___-.02.	O
#acute	O
on	O
chronic	O
systolic	O
CHF/	O
peristent	O
Atrial	O
fibrillation:	O
She	O
appears	O
to	O
never	O
have	O
recovered	O
to	O
functional	O
baseline	O
since	O
surger,	O
with	O
significant	O
DOE	O
with	O
any	O
activity.	O
On	O
exam	O
she	O
did	O
not	O
appear	O
volume	O
overloaded,	O
had	O
no	O
pulmonary	O
edema	O
and	O
remained	O
on	O
room	O
air.	O
TTE	O
with	O
impaired	O
LV	O
systolic	O
function	O
(20%)	O
with	O
the	O
same	O
inferolateral	O
akinesis	O
present	O
in	O
___.	O
TR	O
is	O
now	O
severe.	O
Potential	O
etiologies	O
of	O
her	O
worsening	O
heart	O
failure	O
include	O
ongoing	O
ischemia	O
(less	O
likely	O
given	O
recent	O
cath	O
without	O
progression	O
of	O
disease)	O
or	O
a	O
pressure	O
overloaded	O
LV	O
___	O
her	O
repaired	O
mitral	O
valve.	O
Another	O
possibility	O
felt	O
to	O
be	O
likely	O
was	O
ongoing	O
Afib,	O
which	O
was	O
conducting	O
down	O
her	O
endogenous	O
conduction	O
system	O
and	O
causing	O
her	O
to	O
receive	O
BiVentricular	O
pacing	O
only	O
about	O
60%	O
of	O
the	O
time,	O
leading	O
to	O
ventricular	O
dyssnchrony	O
given	O
her	O
baseline	O
LBBB.	O
Her	O
metoprolol	O
was	O
uptitrated	O
and	O
she	O
underwent	O
AV	O
nodal	O
ablation.	O
After	O
the	O
ablation	O
she	O
was	O
BiV	O
paced	O
100%	O
of	O
the	O
time	O
at	O
a	O
fixed	O
ventricular	O
rate	O
of	O
80.	O
She	O
remained	O
in	O
Afib.	O
Had	O
significant	O
symptomatic	O
improvement.	O
Diuresis	O
was	O
initially	O
attempted	O
but	O
resulted	O
in	O
___	O
as	O
discussed	O
below.	O
On	O
day	O
of	O
discharge,	O
home	O
diuretic	O
restarted.	O
ACE	O
inhibitor	O
was	O
not	O
initiated	O
given	O
___.	O
For	O
her	O
Afib,	O
her	O
home	O
coumadin	O
was	O
continued.	O
___	O
on	O
CKD:	O
Cr	O
between	O
2.1-2.5	O
which	O
is	O
at	O
baseline.	O
Steadily	O
rose	O
with	O
IV	O
diuresis	O
this	O
admission,	O
confirming	O
clinical	O
suspicion	O
that	O
she	O
was	O
not	O
grossly	O
volume	O
overloaded.,	O
indicating	O
that	O
she	O
is	O
not	O
improving	O
with	O
preload	O
reduction.	O
Her	O
elevated	O
JVP	O
is	O
likely	O
a	O
reflection	O
of	O
her	O
now	O
severe	O
TR	O
given	O
her	O
decompensated	O
LV	O
function	O
and	O
worsening	O
pulmonary	O
hypertension.	O
Her	O
diuresis	O
was	O
held	O
until	O
the	O
Cr	O
improved	O
back	O
to	O
baseline.	O
it	O
was	O
2.4	O
on	O
day	O
of	O
discharge	O
and	O
her	O
home	O
torsemide	O
60	O
mg	O
BID	O
was	O
restarted.	O
#DM:	O
continued	O
home	O
Lantus	O
+	O
sliding	O
scale	O
Transitional	O
Issues:	O
-weight	O
on	O
discharge	O
-	O
74kg	O
(pt.	O
appears	O
euvolemic)	O
-cardiology	O
appt	O
1	O
week,	O
PCP	O
___	O
2	O
weeks,	O
EP	O
appt	O
1	O
month	O
-torsemide	O
60	O
mg	O
BID	O
restarted	O
at	O
discharge	O
-recheck	O
Chem7	O
on	O
home	O
torsemide,	O
adjust	O
diuretic	O
prn.	O
-INR	O
check	O
___,	O
results	O
faxed	O
to	O
Dr.	O
___	O
___	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
may	O
be	O
inaccurate	O
and	O
requires	O
futher	O
investigation.	O
1.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Colchicine	O
0.3	O
mg	O
PO	O
DAILY	O
4.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
5.	O
Torsemide	O
60	O
mg	O
PO	O
BID	O
6.	O
Warfarin	O
2	O
mg	O
PO	O
3X/WEEK	O
(___)	O
7.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
8.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
PO	O
BID	O
9.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
TID	O
10.	O
Sucralfate	O
1	O
gm	O
PO	O
BID	O
11.	O
Gabapentin	O
300	O
mg	O
PO	O
DAILY	O
12.	O
Warfarin	O
1	O
mg	O
PO	O
4X/WEEK	O
(___)	O
13.	O
Digoxin	O
0.125	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
14.	O
Glargine	O
50	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
Discharge	O
Medications:	O
1.	O
Digoxin	O
0.0625	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
2.	O
Colchicine	O
0.3	O
mg	O
PO	O
DAILY	O
3.	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Gabapentin	O
300	O
mg	O
PO	O
DAILY	O
5.	O
Glargine	O
50	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
6.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
7.	O
Warfarin	O
2	O
mg	O
PO	O
3X/WEEK	O
(___)	O
8.	O
Warfarin	O
1	O
mg	O
PO	O
4X/WEEK	O
(___)	O
9.	O
Torsemide	O
60	O
mg	O
PO	O
BID	O
10.	O
Sucralfate	O
1	O
gm	O
PO	O
BID	O
11.	O
Amiodarone	O
200	O
mg	O
PO	O
DAILY	O
RX	O
*amiodarone	O
200	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
12.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
13.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
TID	O
14.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
15.	O
Outpatient	O
Lab	O
Work	O
Please	O
have	O
___	O
checked	O
on	O
___.	O
Fax	O
results	O
to	O
Dr.	O
___	O
at	O
___	O
ICD-9:	O
427.31	O
16.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
100	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
17.	O
Lorazepam	O
0.5	O
mg	O
PO	O
Q8H:PRN	O
anxiety	O
RX	O
*lorazepam	O
0.5	O
mg	O
1	O
tab	O
by	O
mouth	O
daily:	O
prn	O
Disp	O
#*14	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary:	O
ventricular	O
tachycardia	O
Atrial	O
fibrillation	O
Secondary:	O
acute	O
on	O
chronic	O
systolic	O
heart	O
failure	O
tricupsid	O
regurgitation	O
diabetes	O
chronic	O
kidney	O
disease	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented,	B-Delirium
clear	B-Delirium
and	B-Delirium
coherent,	B-Delirium
ambulating	B-Independently_mobile
independently	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
___	O
after	O
feeling	O
dizzy	O
and	O
being	O
shocked	O
by	O
your	O
ICD.	O
You	O
had	O
a	O
heart	O
arrythmia,	O
likely	O
a	O
dangerous	O
rhythm	O
called	O
ventricular	O
tachycardia.	O
You	O
were	O
started	O
on	O
a	O
new	O
medication,	O
amiodarone,	O
which	O
you	O
should	O
continue	O
to	O
take	O
daily	O
until	O
otherwise	O
instructed	O
by	O
your	O
cardiologist.	O
We	O
have	O
also	O
increased	O
your	O
home	O
metoprolol	O
and	O
converted	O
it	O
to	O
a	O
long	O
acting	O
version:	O
metoprolol	O
succinate	O
100	O
mg	O
daily.	O
We	O
have	O
also	O
decreased	O
your	O
digoxin	O
dose.	O
Your	O
more	O
chronic	O
symptoms	O
of	O
shortness	O
of	O
breath	O
with	O
activity	O
were	O
thought	O
to	O
be	O
caused	O
by	O
your	O
ongoing	O
atrial	O
fibrillation	O
which	O
was	O
interfering	O
with	O
your	O
pacemaker.	O
You	O
underwent	O
an	O
ablation	O
of	O
your	O
heart	O
conduction	O
system	O
to	O
ensure	O
that	O
you	O
are	O
paced	O
100%	O
of	O
the	O
time	O
and	O
to	O
reduce	O
your	O
chances	O
of	O
having	O
recurrent	O
ventricular	O
tachycardia.	O
Please	O
contnue	O
to	O
weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
It	O
has	O
been	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
the	O
___.	O
-your	O
___	O
care	O
team	O
Followup	O
Instructions:	O
___	O

